Barely Significant
← all excerpts

Mayo Genetic Risk Models for Newly Diagnosed Acute Myeloid Leukemia Treated With Venetoclax + Hypomethylating Agent.

Am J Hematol · 2025 · PMC11705209 · PMID 39671248

Europe PMCDOI
1
hedged sentence
0.0900
closest p · 1.8× alpha
0.0900
boldest claim

The sentences

borderline significantp = 0.09so close (0.05 < p ≤ 0.1)
not reached; p < 0.01) as risk factors for relapse; CRi versus CR were borderline significant (15 vs. 17 months; p = 0.09); on the other hand, IDH2 MUT (not reached vs. 15 months; p < 0.01) were associated with a lower risk of relapse.

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.